TMU Research Center of Cancer Translational Medicine

Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Fingerprint Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

    To Develop Novel Treatment Options for Hepatocellular Carcinoma via Drug Repurposing(2/2)

    Whang-Peng, J.

    8/1/197/31/20

    Project: A - Government Institutionb - Ministry of Science and Technology

    奈米HEVnp於晚期大腸直腸癌患者的治療策略(1/3)相對補助

    Whang-Peng, J.

    8/1/197/31/20

    Project: A - Government Institutionf - Other (Funded by Government)

    Investigating the Oncogenic Roles of A9-Nicotinic Acetylcholine Receptor Variants on Breast Cancer( III )

    Ho, Y.

    8/1/197/31/20

    Project: A - Government Institutionb - Ministry of Science and Technology

    Research Output

    ABL genomic editing sufficiently abolishes oncogenesis of human chronic myeloid leukemia cells in vitro and in vivo

    Chen, S. H., Hsieh, Y. Y., Tzeng, H. E., Lin, C. Y., Hsu, K. W., Chiang, Y. S., Lin, S. M., Su, M. J., Hsieh, W. S. & Lee, C. H., Jun 2020, In : Cancers. 12, 6, 1399.

    Research output: Contribution to journalArticle

    Open Access
  • Anaplastic lymphoma kinase inhibitors: an updated patent review (2014–2018)

    Liu, Y. M., Kuo, C. N. & Liou, J. P., Jan 1 2020, (Accepted/In press) In : Expert Opinion on Therapeutic Patents.

    Research output: Contribution to journalReview article